{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:13:48Z","timestamp":1779207228657,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chr. Hansen A\/S and Hvidovre Hospital"},{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09679-3","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T02:28:42Z","timestamp":1775528922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of the probiotic supplement\u2014ASTARTE\u2122\u2014on the reduction of recurrent urinary tract infection in women aged 18-40 years: protocol for a randomized, double-blind, placebo-controlled study"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0964-4059","authenticated-orcid":false,"given":"Khaled Saoud Ali","family":"Ghathian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie Ingdam","family":"Halkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Angeliki","family":"Krogfelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Frimodt-M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrine Hartung","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalie Kruse Sigersted","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas Munk","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"9679_CR1","doi-asserted-by":"crossref","unstructured":"Akg\u00fcl T, Karakan T. 377 FEMALE UROLOGY The role of probiotics in women with recurrent urinary tract infections. J Urol [Internet]. 2018 [cited 2022 Jan 2];44(5):377\u201383. Available from: www.turkishjournalofurology.com.","DOI":"10.5152\/tud.2018.48742"},{"key":"9679_CR2","doi-asserted-by":"publisher","unstructured":"Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:1756287219832172. https:\/\/doi.org\/10.1177\/1756287219832172. PMID: 31105774; PMCID: PMC6502976.","DOI":"10.1177\/1756287219832172"},{"key":"9679_CR3","doi-asserted-by":"crossref","unstructured":"Anger J, Lee U, Ackerman AL, Chou R, Chughtai B, Clemens JQ, et al. Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline. J Urol. 2019;202(2):282\u20139.","DOI":"10.1097\/JU.0000000000000296"},{"key":"9679_CR4","doi-asserted-by":"crossref","unstructured":"Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018;219(1):40\u201351.","DOI":"10.1016\/j.ajog.2017.12.231"},{"issue":"1","key":"9679_CR5","doi-asserted-by":"publisher","first-page":"29000","DOI":"10.1038\/srep29000","volume":"6","author":"SY Leclercq","year":"2016","unstructured":"Leclercq SY, Sullivan MJ, Ipe DS, Smith JP, Cripps AW, Ulett GC. Pathogenesis of Streptococcus urinary tract infection depends on bacterial strain and \u03b2-hemolysin\/cytolysin that mediates cytotoxicity, cytokine synthesis, inflammation and virulence. Sci Rep. 2016;6(1):29000.","journal-title":"Sci Rep."},{"key":"9679_CR6","doi-asserted-by":"crossref","unstructured":"Stephens K, Charnock-Jones DS, Smith GCS. Group B streptococcus and the risk of perinatal morbidity and mortality following term labor. Am J Obstet Gynecol. 2023;228(5):S1305\u201312.","DOI":"10.1016\/j.ajog.2022.07.051"},{"key":"9679_CR7","doi-asserted-by":"crossref","unstructured":"Holm A, Cordoba G, Aabenhus R. Scandinavian Journal of Primary Health Care Prescription of antibiotics for urinary tract infection in general practice in Denmark Prescription of antibiotics for urinary tract infection in general practice in Denmark. Primary Health Care [Internet]. 2019 [cited 2022 Jan 2];37(1):83\u20139. Available from: https:\/\/www.tandfonline.com\/action\/journalInformation?journalCode=ipri20.","DOI":"10.1080\/02813432.2019.1569425"},{"key":"9679_CR8","doi-asserted-by":"publisher","unstructured":"Bilsen MP, Jongeneel RMH, Schneeberger C, Platteel TN, Van Nieuwkoop C, Mody L, et al. Definitions of urinary tract infection in current research: a systematic review. Open Forum Infectious Diseases. 2023;10(7):1\u20138. https:\/\/doi.org\/10.1093\/ofid\/ofad332.","DOI":"10.1093\/ofid\/ofad332"},{"key":"9679_CR9","doi-asserted-by":"crossref","unstructured":"Mazor-Dray E, Levy A, Schlaeffer F, Sheiner E. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med [Internet]. 2009 Feb [cited 2022 Jan 11];22(2):124\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19085630\/.","DOI":"10.1080\/14767050802488246"},{"issue":"6","key":"9679_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2042098614554919","volume":"5","author":"C Llor","year":"2014","unstructured":"Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229\u201341.","journal-title":"Ther Adv Drug Saf."},{"key":"9679_CR11","doi-asserted-by":"crossref","unstructured":"Bassetti S, Tschudin-Sutter S, Egli A, Osthoff M. Optimizing antibiotic therapies to reduce the risk of bacterial resistance. Eur J Intern Med. 2022;99:7\u201312.","DOI":"10.1016\/j.ejim.2022.01.029"},{"key":"9679_CR12","doi-asserted-by":"crossref","unstructured":"Mancuso G, Midiri A, Gerace E, Marra M, Zummo S, Biondo C. Urinary tract infections: the current scenario and future prospects. Pathogens. 2023;12(4):623.","DOI":"10.3390\/pathogens12040623"},{"key":"9679_CR13","doi-asserted-by":"crossref","unstructured":"Scott VCS, Thum LW, Sadun T, Markowitz M, Maliski SL, Ackerman AL, et al. Fear and frustration among women with recurrent urinary tract infections: findings from patient focus groups. J Urol. 2021;206(3):688\u201395.","DOI":"10.1097\/JU.0000000000001843"},{"key":"9679_CR14","doi-asserted-by":"publisher","unstructured":"Ru\u021ba F, Pribac M, Mardale E, Suciu S, Maior R, Bogdan S, et al. Associations between gut microbiota dysbiosis and other risk factors in women with a history of urinary tract infections. Nutrients. 2024. https:\/\/doi.org\/10.3390\/nu16111753.","DOI":"10.3390\/nu16111753"},{"key":"9679_CR15","doi-asserted-by":"publisher","unstructured":"Stapleton AE. The vaginal microbiota and urinary tract infection. Microbiol Spectr. 2016. https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0025-2016.","DOI":"10.1128\/microbiolspec.UTI-0025-2016"},{"key":"9679_CR16","doi-asserted-by":"crossref","unstructured":"Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE. Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women. Infect Dis Obstet Gynecol. 2007;2007(1):8.","DOI":"10.1155\/2007\/35387"},{"key":"9679_CR17","doi-asserted-by":"publisher","unstructured":"Kinashi Y, Hase K. Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity. Front Immunol. 2021;12:673708. https:\/\/doi.org\/10.3389\/fimmu.2021.673708. PMID: 33968085; PMCID: PMC8100306.","DOI":"10.3389\/fimmu.2021.673708"},{"key":"9679_CR18","doi-asserted-by":"publisher","unstructured":"Christovich A, Luo XM. Gut Microbiota, Leaky Gut, and Autoimmune Diseases. Front Immunol. 2022;13:946248. https:\/\/doi.org\/10.3389\/fimmu.2022.946248. PMID: 35833129; PMCID: PMC9271567.","DOI":"10.3389\/fimmu.2022.946248"},{"key":"9679_CR19","doi-asserted-by":"crossref","unstructured":"Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis [Internet]. 2011 May 15 [cited 2022 Jan 2];52(10):1212\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21498386\/.","DOI":"10.1093\/cid\/cir183"},{"key":"9679_CR20","doi-asserted-by":"publisher","unstructured":"Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015;2015(12):CD008772. https:\/\/doi.org\/10.1002\/14651858.CD008772.pub2. PMID: 26695595; PMCID: PMC8720415.","DOI":"10.1002\/14651858.CD008772.pub2"},{"key":"9679_CR21","doi-asserted-by":"crossref","unstructured":"Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care. 1994;12(4):239\u2013243.","DOI":"10.3109\/02813439409029247"},{"key":"9679_CR22","doi-asserted-by":"crossref","unstructured":"Lee SJ, Shim YH, Cho SJ, Lee JW. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol. 2007;22(9):1315\u20131320.","DOI":"10.1007\/s00467-007-0507-1"},{"key":"9679_CR23","doi-asserted-by":"crossref","unstructured":"Kontiokari T. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in. BMJ. 2001;322(7302):1571\u20131571.","DOI":"10.1136\/bmj.322.7302.1571"},{"key":"9679_CR24","doi-asserted-by":"crossref","unstructured":"Sharma R, Schumacher U. Morphometric analysis of intestinal mucins under different dietary conditions and gut flora in rats. Dig Dis Sci [Internet]. 1995 Dec [cited 2022 Jan 2];40(12):2532\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/8536508\/.","DOI":"10.1007\/BF02220438"},{"key":"9679_CR25","doi-asserted-by":"crossref","unstructured":"Lu L, Walker WA. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr [Internet]. 2001 [cited 2022 Jan 2];73(6). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11393190\/.","DOI":"10.1093\/ajcn\/73.6.1124S"},{"key":"9679_CR26","doi-asserted-by":"crossref","unstructured":"Bodke H, Jogdand S. Role of probiotics in human health. Cureus. 2022.","DOI":"10.7759\/cureus.31313"},{"key":"9679_CR27","unstructured":"Chr. Hansen A\/S part of N. 2022. https:\/\/www.chr-hansen.com\/en\/human-health-and-probiotics\/our-probiotic-strains\/astarte. Chr. Hansen\u2019s probiotic combination\u2013ASTARTETM."},{"key":"9679_CR28","doi-asserted-by":"crossref","unstructured":"Laue C, Papazova E, Liesegang A, Pannenbeckers A, Arendarski P, Linnerth B, et al. Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women\u2013a double-blind, randomised, controlled clinical pilot trial. Benef Microbes. 2018;9(1):35\u201350.","DOI":"10.3920\/BM2017.0018"},{"key":"9679_CR29","doi-asserted-by":"crossref","unstructured":"Kiss H, K\u00f6gler B, Petricevic L, Sauerzapf I, Klayraung S, Domig K, et al. Vaginal Lactobacillus microbiota of healthy women in the late first trimester of pregnancy. BJOG. 2007;114(11):1402\u20131407.","DOI":"10.1111\/j.1471-0528.2007.01412.x"},{"key":"9679_CR30","doi-asserted-by":"crossref","unstructured":"Brookes ST, Donovan JL, Wright M, Jackson S, Abrams P. A scored form of the Bristol female lower urinary tract symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence Am J Obstet Gynecol 2004;191(1):73\u201382.","DOI":"10.1016\/j.ajog.2003.12.027"},{"key":"9679_CR31","doi-asserted-by":"crossref","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u2013281.","DOI":"10.1111\/j.1469-0691.2011.03570.x"},{"key":"9679_CR32","doi-asserted-by":"publisher","unstructured":"Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child. 1995;72(1):51\u20133. https:\/\/doi.org\/10.1136\/adc.72.1.51. PMID: 7717739; PMCID: PMC1510973.","DOI":"10.1136\/adc.72.1.51"},{"key":"9679_CR33","doi-asserted-by":"crossref","unstructured":"Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2015;31(1):69\u201375.","DOI":"10.1097\/MOG.0000000000000139"},{"key":"9679_CR34","doi-asserted-by":"crossref","unstructured":"Finucane TE. \u2018Urinary tract infection\u2019 and the microbiome. Am J Med. 2017;130(3):e97\u2013e98.","DOI":"10.1016\/j.amjmed.2016.08.018"},{"key":"9679_CR35","doi-asserted-by":"crossref","unstructured":"Amabebe E, Anumba DOC. Female gut and genital tract microbiota-induced crosstalk and differential effects of short-chain fatty acids on immune sequelae. Front Immunol. 2020;10:11.","DOI":"10.3389\/fimmu.2020.02184"},{"key":"9679_CR36","doi-asserted-by":"crossref","unstructured":"den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325\u201340.","DOI":"10.1194\/jlr.R036012"},{"key":"9679_CR37","doi-asserted-by":"crossref","unstructured":"Adu-Oppong B, Th\u00e4nert R, Wallace MA, Burnham CAD, Dantas G. Substantial overlap between symptomatic and asymptomatic genitourinary microbiota states. Microbiome. 2022;10(1):6.","DOI":"10.1186\/s40168-021-01204-9"},{"key":"9679_CR38","doi-asserted-by":"crossref","unstructured":"Ranjan R, Rani A, Metwally A, McGee HS, Perkins DL. Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem Biophys Res Commun. 2016;469(4):967\u201377.","DOI":"10.1016\/j.bbrc.2015.12.083"},{"key":"9679_CR39","doi-asserted-by":"publisher","unstructured":"Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis. 2013;13:19. https:\/\/doi.org\/10.1186\/1471-2334-13-19. PMID: 23327474; PMCID: PMC3556060.","DOI":"10.1186\/1471-2334-13-19"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09679-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09679-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09679-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:53:30Z","timestamp":1779206010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09679-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9679"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09679-3","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Danish Data Protection Agency (P-2022\u2013356), and permission for human experiments and recruitment of participants has been obtained from the Scientific Ethics Committee for Copenhagen Regional Hospital before initiation and approved by the Danish Data Protection Agency (H-22014666). As probiotics are considered dietary supplements and not pharmaceuticals, no authorization by the Danish Medicines Agency is required. The study is performed in accordance with the requirements of the Revised Declaration of Helsinki. The study is registered at ClinicalTrials.gov (NCT05553652) before inclusion of the first participant. Consent for participation will be obtained from all participants, and participants can discontinue at any time point on their request. Sample materials are temporarily stored in a Research Biobank if there is a need for reanalysis or possibly additional analysis to collect data related to this project. The end date for the research biobank is 01.08.2032. No additional consent provisions are needed for the collection and use of participant data and biological specimens in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"No personal data is published in this protocol article. Consent from participants is obtained\/will be obtained to publish the data as anonymous data when the study is completed. The participant information and consent form are available as supplementary material in both Danish and English.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"AKSF is an employee of Chr. Hansen A\/S, part of Novonesis Group, but will not be involved in the study conduct, data management or statistical analysis. The rest of the authors report no other conflicts of interest in this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"383"}}